Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amit Munshi currently holds 38,176 shares of Inhibikase Therapeutics, Inc. (IKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amit Munshi has been a net seller of IKT stock. They have purchased $1.5M and sold $29.2M worth of shares.
Amit Munshi's most recent insider trade was on Feb 21, 2026, when they sold 19,089 shares at $0.00 per share.
Amit Munshi serves as Executive at Inhibikase Therapeutics, Inc. (IKT). They have executed 70 insider transactions totaling $30.7M over their tenure at the company.
Amit Munshi holds the position of Executive at Inhibikase Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Amit Munshi has shown a selling trading pattern, with $1.5M in total purchases and $29.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Amit Munshi was on Jan 19, 2021, when they sold $4.0M worth of ARNA shares. This transaction involved 50,000 shares at $80.14 per share.
Amit Munshi currently owns 38,176 shares of Inhibikase Therapeutics, Inc. (IKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amit Munshi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amit Munshi has 70 Form 4 filings on record as an insider at Inhibikase Therapeutics, Inc..
Set alerts for Amit Munshi and 40,000+ other insiders.